Cited by 50

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

MicroRNA-155 Tunes Both the Threshold and Extent of NK Cell Activation via Targeting of Multiple Signaling Pathways

Sullivan, Ryan P, Fogel, Leslie A, Leong, Jeffrey W, Schneider, Stephanie E, Wong, Rachel, Romee, Rizwan, Thai, To-Ha, Sexl, Veronika, Matkovich, Scot J, Dorn, Gerald W, French, Anthony R, Fehniger, Todd A·2013·The Journal of Immunology

Abstract

NK cells are innate lymphocytes important for host defense against viral infections and malignancy. However, the molecular programs orchestrating NK cell activation are incompletely understood. MicroRNA-155 (miR-155) is markedly upregulated following cytokine activation of human and mouse NK cells. Surprisingly, mature human and mouse NK cells transduced to overexpress miR-155, NK cells from mice with NK cell–specific miR-155 overexpression, and miR-155−/− NK cells all secreted more IFN-γ compared with controls. Investigating further, we found that activated NK cells with miR-155 overexpression had increased per-cell IFN-γ with normal IFN-γ+ percentages, whereas greater percentages of miR-155−/− NK cells were IFN-γ+. In vivo murine CMV–induced IFN-γ expression by NK cells in these miR-155 models recapitulated the in vitro phenotypes. We performed unbiased RNA-induced silencing complex sequencing on wild-type and miR-155−/− NK cells and found that mRNAs targeted by miR-155 were enriched in NK cell activation signaling pathways. Using specific inhibitors, we confirmed these pathways were mechanistically involved in regulating IFN-γ production by miR-155−/− NK cells. These data indicate that miR-155 regulation of NK cell activation is complex and that miR-155 functions as a dynamic tuner for NK cell activation via both setting the activation threshold as well as controlling the extent of activation in mature NK cells. In summary, miR-155−/− NK cells are more easily activated, through increased expression of proteins in the PI3K, NF-κB, and calcineurin pathways, and miR-155−/− and 155-overexpressing NK cells exhibit increased IFN-γ production through distinct cellular mechanisms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1301950

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 3 references

Research works printed but not linked: 40

  1. Yokoyama, 2004, The dynamic life of natural killer cells, Annu. Rev. Immunol., 22, 405, 10.1146/annurev.immunol.22.012703.104711 · DOI
  2. Di Santo, 2006, Natural killer cell developmental pathways: a question of balance, Annu. Rev. Immunol., 24, 257, 10.1146/annurev.immunol.24.021605.090700 · DOI
  3. Lanier, 2005, NK cell recognition, Annu. Rev. Immunol., 23, 225, 10.1146/annurev.immunol.23.021704.115526 · DOI
  4. Orange, 2008, Formation and function of the lytic NK-cell immunological synapse, Nat. Rev. Immunol., 8, 713, 10.1038/nri2381 · DOI
  5. Tripathy, 2008, Continuous engagement of a self-specific activation receptor induces NK cell tolerance, J. Exp. Med., 205, 1829, 10.1084/jem.20072446 · DOI
  6. Elliott, 2010, MHC class I-deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I-sufficient environment, J. Exp. Med., 207, 2073, 10.1084/jem.20100986 · DOI
  7. Höglund, 2010, Current perspectives of natural killer cell education by MHC class I molecules, Nat. Rev. Immunol., 10, 724, 10.1038/nri2835 · DOI
  8. Long, 2013, Controlling natural killer cell responses: integration of signals for activation and inhibition, Annu. Rev. Immunol., 31, 227, 10.1146/annurev-immunol-020711-075005 · DOI
  9. Hesslein, 2011, Transcriptional control of natural killer cell development and function, Adv. Immunol., 109, 45, 10.1016/B978-0-12-387664-5.00002-9 · DOI
  10. Ramirez, 2010, Multiple hats for natural killers, Curr. Opin. Immunol., 22, 193, 10.1016/j.coi.2010.02.002 · DOI
  11. Lewis, 2005, Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets, Cell, 120, 15, 10.1016/j.cell.2004.12.035 · DOI · Paper page
  12. Garzon, 2009, MicroRNAs in Cancer, Annu. Rev. Med., 60, 167, 10.1146/annurev.med.59.053006.104707 · DOI
  13. O’Connell, 2012, microRNA regulation of inflammatory responses, Annu. Rev. Immunol., 30, 295, 10.1146/annurev-immunol-020711-075013 · DOI · Paper page
  14. Baltimore, 2008, MicroRNAs: new regulators of immune cell development and function, Nat. Immunol., 9, 839, 10.1038/ni.f.209 · DOI
  15. Bezman, 2010, Distinct requirements of microRNAs in NK cell activation, survival, and function, J. Immunol., 185, 3835, 10.4049/jimmunol.1000980 · DOI
  16. Sullivan, 2012, MicroRNA-deficient NK cells exhibit decreased survival but enhanced function, J. Immunol., 188, 3019, 10.4049/jimmunol.1102294 · DOI
  17. Thomas, 2012, Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function, Blood, 120, 130, 10.1182/blood-2011-11-394072 · DOI
  18. Leong, 2012, Natural killer cell regulation by microRNAs in health and disease, J. Biomed. Biotechnol., 2012, 632329, 10.1155/2012/632329 · DOI
  19. Sullivan, 2013, MicroRNA regulation of natural killer cells, Front Immunol, 4, 44, 10.3389/fimmu.2013.00044 · DOI
  20. Beaulieu, 2013, MicroRNA function in NK-cell biology, Immunol. Rev., 253, 40, 10.1111/imr.12045 · DOI
  21. Trotta, 2012, miR-155 regulates IFN-γ production in natural killer cells, Blood, 119, 3478, 10.1182/blood-2011-12-398099 · DOI
  22. Trotta, 2013, Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells, Blood, 121, 3126, 10.1182/blood-2012-12-467597 · DOI
  23. Thai, 2007, Regulation of the germinal center response by microRNA-155, Science, 316, 604, 10.1126/science.1141229 · DOI
  24. O’Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc. Natl. Acad. Sci. USA, 104, 1604, 10.1073/pnas.0610731104 · DOI · Paper page
  25. O’Connell, 2009, Inositol phosphatase SHIP1 is a primary target of miR-155, Proc. Natl. Acad. Sci. USA, 106, 7113, 10.1073/pnas.0902636106 · DOI · Paper page
  26. Fehniger, 2010, Next-generation sequencing identifies the natural killer cell microRNA transcriptome, Genome Res., 20, 1590, 10.1101/gr.107995.110 · DOI
  27. Zawislak, 2013, Stage-specific regulation of natural killer cell homeostasis and response against viral infection by microRNA-155, Proc. Natl. Acad. Sci. USA, 110, 6967, 10.1073/pnas.1304410110 · DOI
  28. Eckelhart, 2011, A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development, Blood, 117, 1565, 10.1182/blood-2010-06-291633 · DOI
  29. Jonsson, 2010, Effects of MHC class I alleles on licensing of Ly49A+ NK cells, J. Immunol., 184, 3424, 10.4049/jimmunol.0904057 · DOI
  30. van Rossum, 2008, Variation in leukocyte subset concentrations affects calcineurin activity measurement: implications for pharmacodynamic monitoring strategies, Clin. Chem., 54, 517, 10.1373/clinchem.2007.097253 · DOI
  31. Ortaldo, 2001, Activating Ly-49 NK receptors: central role in cytokine and chemokine production, J. Immunol., 166, 4994, 10.4049/jimmunol.166.8.4994 · DOI
  32. Bahner, 2007, Lentiviral vector transduction of a dominant-negative Rev gene into human CD34+ hematopoietic progenitor cells potently inhibits human immunodeficiency virus-1 replication, Mol. Ther., 15, 76, 10.1038/sj.mt.6300025 · DOI
  33. Brown, 2001, Vital involvement of a natural killer cell activation receptor in resistance to viral infection, Science, 292, 934, 10.1126/science.1060042 · DOI
  34. Fogel, 2013, Markers of nonselective and specific NK cell activation, J. Immunol., 190, 6269, 10.4049/jimmunol.1202533 · DOI
  35. Matkovich, 2011, RISC RNA sequencing for context-specific identification of in vivo microRNA targets, Circ. Res., 108, 18, 10.1161/CIRCRESAHA.110.233528 · DOI
  36. Karginov, 2007, A biochemical approach to identifying microRNA targets, Proc. Natl. Acad. Sci. USA, 104, 19291, 10.1073/pnas.0709971104 · DOI · Paper page
  37. Garcia, 2011, Weak seed-pairing stability and high target-site abundance decrease the proficiency of lsy-6 and other microRNAs, Nat. Struct. Mol. Biol., 18, 1139, 10.1038/nsmb.2115 · DOI
  38. Loeb, 2012, Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting, Mol. Cell, 48, 760, 10.1016/j.molcel.2012.10.002 · DOI · Paper page
  39. Banh, 2012, Mouse natural killer cell development and maturation are differentially regulated by SHIP-1, Blood, 120, 4583, 10.1182/blood-2012-04-425009 · DOI
  40. Li, 2007, miR-181a is an intrinsic modulator of T cell sensitivity and selection, Cell, 129, 147, 10.1016/j.cell.2007.03.008 · DOI

Cited by

Sorted by citations

See all 50

Metadata

Authors
Sullivan, R. P., Fogel, L. A., Leong, J. W., Schneider, S. E., Wong, R., Romee, R., Thai, T.-H., Sexl, V., Matkovich, S. J., Dorn, G. W., French, A. R., & Fehniger, T. A.
Affiliations
  • Division of Oncology, Department of Medicine, Washington University School of Medicine , St. Louis, MO 63110
  • Division of Rheumatology, Department of Pediatrics, Washington University School of Medicine , St. Louis, MO 63110
  • Beth Israel Deaconess Medical Center and Harvard Medical School , Boston, MA 02155
  • Institute of Pharmacology and Toxicology, Veterinary University of Vienna , Vienna A-1210,
  • Center for Pharmacogenomics, Washington University School of Medicine , St. Louis, MO 63110
Venue
The Journal of Immunology
Published
2013-12
Volume
191
Issue
12
Pages
5904-5913
ISSN
  • 0022-1767
  • 1550-6606
Cited by
50
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review